- Home
- ARDX vs SBGI Comparison
ARDX vs SBGI Comparison
Compare ARDX & SBGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARDX
- SBGI
- Stock Information
- Founded
- ARDX 2007
- SBGI 1986
- Country
- ARDX United States
- SBGI United States
- Employees
- ARDX N/A
- SBGI N/A
- Industry
- ARDX Biotechnology: Pharmaceutical Preparations
- SBGI Broadcasting
- Sector
- ARDX Health Care
- SBGI Industrials
- Exchange
- ARDX Nasdaq
- SBGI Nasdaq
- Market Cap
- ARDX 1.2B
- SBGI 1.1B
- IPO Year
- ARDX 2014
- SBGI 1995
- Fundamental
- Price
- ARDX $4.91
- SBGI $14.50
- Analyst Decision
- ARDX Buy
- SBGI Buy
- Analyst Count
- ARDX 7
- SBGI 5
- Target Price
- ARDX $10.58
- SBGI $20.10
- AVG Volume (30 Days)
- ARDX 5.0M
- SBGI 226.4K
- Earning Date
- ARDX 02-20-2025
- SBGI 02-26-2025
- Dividend Yield
- ARDX N/A
- SBGI 6.91%
- EPS Growth
- ARDX N/A
- SBGI N/A
- EPS
- ARDX N/A
- SBGI N/A
- Revenue
- ARDX $251,849,000.00
- SBGI $3,370,000,000.00
- Revenue This Year
- ARDX $168.07
- SBGI $14.93
- Revenue Next Year
- ARDX $16.66
- SBGI N/A
- P/E Ratio
- ARDX N/A
- SBGI N/A
- Revenue Growth
- ARDX 87.57
- SBGI 3.12
- 52 Week Low
- ARDX $4.32
- SBGI $11.13
- 52 Week High
- ARDX $10.13
- SBGI $18.45
- Technical
- Relative Strength Index (RSI)
- ARDX 44.85
- SBGI 29.61
- Support Level
- ARDX $4.98
- SBGI $15.39
- Resistance Level
- ARDX $6.07
- SBGI $16.09
- Average True Range (ATR)
- ARDX 0.37
- SBGI 0.62
- MACD
- ARDX -0.01
- SBGI -0.17
- Stochastic Oscillator
- ARDX 4.92
- SBGI 3.74
About ARDX Ardelyx Inc.
Ardelyx Inc is a biotechnology company focused on the discovery, development, and commercialization of innovative, first-in-class medicines that meet significant unmet medical needs. The company has a proprietary drug discovery and design platform. Its lead product candidate is tenapanor, which aims to reduce the absorption of dietary sodium and phosphorus for the treatment of kidney disease, irritable bowel syndrome with constipation, and hyperphosphatemia in patients with dialysis.
About SBGI Sinclair Inc.
Sinclair Inc. is the owner-operator of the second largest portfolio of television stations in the United States, with 185 full power stations in 86 markets. Of the firm's roughly 600 channels, 150 are affiliated with the four national broadcasters—Fox, ABC, CBS, and NBC—with over 80 other channels aligned with The CW (Nexstar) and MyNetworkTV (Fox). Sinclair owns the Tennis Channel and stakes in Marquee Sports Network and YES Network, providing their content to pay-TV distributors.